BiotechTube

Tacrolimus/Sirolimus + Tacrolimus/MMF + Neoral/Sirolimus

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Adult Primary Kidney Transplantation

Conditions

Adult Primary Kidney Transplantation

Trial Timeline

May 1, 2000 → Dec 1, 2002

NCT ID
NCT00681213

About Tacrolimus/Sirolimus + Tacrolimus/MMF + Neoral/Sirolimus

Tacrolimus/Sirolimus + Tacrolimus/MMF + Neoral/Sirolimus is a approved stage product being developed by Roche for Adult Primary Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00681213. Target conditions include Adult Primary Kidney Transplantation.

What happened to similar drugs?

8 of 20 similar drugs in Adult Primary Kidney Transplantation were approved

Approved (8) Terminated (3) Active (11)
✅BenralizumabAstraZenecaApproved
✅FluMist + inactivated influenza vaccineAstraZenecaApproved
✅Saizen® solution for injection (referred as Saizen®)MerckApproved
✅Aztreonam lysineGilead SciencesApproved
✅maraviroc + Raltegravir + Darunavir/ritonavirPfizerApproved
✅SabrilLundbeckApproved
✅NaCl 0.9% in Glucose 5% with 40mEq Potassium + Glucion 5%BaxterApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00681213ApprovedCompleted

Competing Products

20 competing products in Adult Primary Kidney Transplantation

See all competitors
ProductCompanyStageHype Score
BBP-398 + sotorasibBridgeBio PharmaPhase 1
18
Daridorexant + PlaceboIdorsiaPhase 1
23
SON-1010 (IL12-FHAB)Sonnet BioTherapeuticsPhase 1
23
SomatropinEli LillyPhase 3
40
agenT-797MiNK TherapeuticsPhase 1
19
PegilodecakinEli LillyPhase 1
29
eFT226 + Sotorasib + Fulvestrant + Abemaciclib + TrastuzumabeFFECTOR TherapeuticsPhase 1/2
29
Lazertinib(G001) + Lazertinib(G002)YuhanPhase 1
29
Patritumab deruxtecanDaiichi SankyoPhase 2
27
DJ-927 + capecitabineDaiichi SankyoPhase 1
29
Valemetostat TosylateDaiichi SankyoPhase 2
35
RoxadustatAstellas PharmaPhase 1
29
ASP3325 + PlaceboAstellas PharmaPhase 1
29
TRK-100STPAstellas PharmaPhase 1
29
EnsitrelvirShionogiPhase 1
29
E6130 + PlaceboEisaiPhase 1
29
E7389 + E7389 + E7389EisaiPhase 1
29
Eribulin MesylateEisaiPhase 1
29
E2022 + E2022 + E2022 + E2022 + E2022EisaiPhase 1
29
Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil HydrochlorideEisaiPhase 1
29